explore -WSS

explore

author：entertainment 2025-09-30 06:22:35 - browse：7

Electrocardiogram in the shape of the United States map — Adobe

The market for artificial intelligence in health care is about as transparent as a brick wall. New tools achieve impressive results in published studies. But it is often difficult to compare them head to head with similar products, or tell whether they will work on different kinds of patients.

A new company is promising to change that — if it can convince AI developers to expose their products to more rigorous testing.

Called Dandelion Health, the New York-based firm is launching a first-of-its-kind public service to evaluate AI products on independent data designed to root out weaknesses and reveal bias. The company said Wednesday its initial pilot program, to begin next month, will focus on testing algorithms that use electrocardiograms to predict heart conditions.

Unlock this article by subscribing to STAT+ and enjoy your first 30 days free!

GET STARTED Log In

Previous article： Peter Hotez and the public health issue of online harassment
Next article： Adam's Take: Intra

entertainment

WSS

Hilary may become 1st tropical storm to make landfall in California in 84 years

The pain doctors face in trying to build their families

Patient advocates sound warning on FDA proposal on salt intake

6 surprising facts about sugar

U.K. officials, researchers try to ease path for bespoke genetic treatments

Trump's false claims about Georgia's 2020 election long debunked

hotspot

explore

knowledge

Activists slam private health insurers over coverage restrictions

Biotech investment managers search for lucrative opportunities

At least 13 dead in Texas as scorching temps continue

Patient advocates sound warning on FDA proposal on salt intake

Cancer drug shortages should be causing more outrage

New definition of a human embryo proposed amid rapid advances

Drug repurposing or repositioning? The language matters

ActiGraph execs on goal of drug approvals with digital endpoints

New air purifier tech could be key to improving indoor air quality

Cancer drug shortages' outsize impact on ovarian cancer patients

explore

Liz Cheney makes 1st public comment since Trump's election interference indictments

Listen: Racing for gene therapy & a pioneering approval

Asbestos ban is immediate, but health effects will linger for decades

Biotech investment managers search for lucrative opportunities

Texas board proposes rules on abortion law emergency exemption

ProMED sees offers of support, but its future remains unclear

knowledge

focus

entertainment

focus